NRXP
NRX PHARMA (NRXP)
NASDAQ
$2.94+$0.09 (+3.02%)
Price as of Oct 02, 2026 6:33 PM EDT
  • $123.4M
    Market Cap
  • -14.41%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
ARMISTICE CAPITAL, LLC
14.46%
6.3M
+6.3M (+100.00%)
Mar 31, 2022
B GROUP, INC.
9.45%
4.1M
+1.1M (+26.68%)
Jun 30, 2026
VANGUARD CAPITAL MANAGEMENT LLC
3.74%
1.6M
+457,975 (+28.30%)
Jun 30, 2026
N/A
2.68%
1.2M
+1.2M (+100.00%)
Mar 31, 2026
AMERIPRISE FINANCIAL INC
2.15%
928,728
+928,728 (+100.00%)
Jun 30, 2026
BALYASNY ASSET MANAGEMENT L.P.
2.06%
893,864
+893,864 (+100.00%)
Jun 30, 2026
VANGUARD GROUP INC
1.69%
729,842
+194,886 (+26.70%)
Dec 31, 2025

Current Ownership Distribution

  • Institutions56.8M (57.31%)
  • Mutual Funds26.5M (26.77%)
  • Insiders15.8M (15.92%)
  • Other0 (0.00%)

Insider Transactions

  • 15.92% (15.8M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Casper Joseph Michael
Chief Operating Officer
Award
Jan 27, 2026
$0.00
100,000
$0.00
100,000
Javitt Jonathan C
Chairman and Chief Scientist
Award
Apr 09, 2025
$0.00
125,000
$0.00
125,000
McBride Dennis
Award
Apr 09, 2025
$0.00
25,000
$0.00
25,000
Hurvitz Chaim
Award
Apr 09, 2025
$0.00
25,000
$0.00
25,000
Flynn Patrick John
Award
Apr 09, 2025
$0.00
50,000
$0.00
50,000
ABRAMS MICHAEL S
Chief Financial Officer
Award
Feb 07, 2025
$0.00
50,000
$0.00
50,000